Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Aripiprazole 5mg
DRUG
2 trials
Sponsors
Massachusetts General Hospital
, Central South University
Conditions
Major Depressive Disorder
Major Depressive Disorder (MDD)
Rumination
Phase 3
A Double-Blind, Placebo-Controlled Study of Aripiprazole Adjunctive to Antidepressant Therapy
Completed
NCT00683852
Massachusetts General Hospital
Major Depressive Disorder
Start: 2008-09-30
End: 2009-09-30
Updated: 2017-07-19
Unknown Phase
Neurobiological Mechanisms of Pathological Rumination and Effects of Aripiprazole
Active, not recruiting
NCT06937476
Central South University
Major Depressive Disorder (MDD), Rumination
Start: 2025-05-08
End: 2026-07-16
Updated: 2026-06-12
Related Papers
Efficacy of dose increase among nonresponders to low-dose aripiprazole augmentation in patients with inadequate response to antidepressant treatment: a randomized, double-blind, placebo-controlled, efficacy trial.
2011-09-20
14 citations